BESREMi is a preferred, FDA-approved option for both symptomatic low- and high-risk polycythemia vera patients. In the polycythemia vera space, BESREMi faces competition from drugs like ruxolitinib, a ...
Francisco 'Paquito' Torres, manejador artístico de Paquita la del Barrio, compartió en exclusiva para Hoy Día algunos ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback